Correction: Anti-tumor effects of ONC201 in combination with VEGF-inhibitors significantly impacts colorectal cancer growth and survival in vivo through complementary non-overlapping mechanisms
J Exp Clin Cancer Res. 2024 Sep 11;43(1):257.
doi: 10.1186/s13046-024-03185-7.
1 Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Molecular Therapeutics Program and Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA.
2 NexusPharma, Inc., Philadelphia, PA, USA.
3 Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Molecular Therapeutics Program and Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA. wafik.eldeiry@fccc.edu.